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Summary findings
Over the past three decades, China has made  What accounts for relatively stagnant, even
commendable strides in improving the health status of its  deteriorating health indicators, and what strategies
population. Between 1965 and  1995, its infant mortality  should be designed to address them as China enters the
rate declined from 90 per 1,000 live births to 36. During  21st century? Overall, Hossain argues, the recent erosion
the same period, life expectancy at birth rose from 55 to  in health gains stems from three factors:
69 years and the maternal mortality rate fell from 26 to  * Changes in government financing of the health
15 per 100,000 deliveries.  sector have increased inequity, inefficiencies, and costs
This performance compares favorably with that in  for medical treatment.
similar Asian economies. China's infant mortality rate,  * The main contributors to the burden of disease have
for example, was less than  half the rate predicted for its  shifted from maternal conditions and infectious diseases
income level. Similarly, life expectancy at birth was  toward noncommunicable diseases and injuries, the
higher than that in many comparable Asian countries.  prevention of which has not been a traditional part of
These favorable results conceal more recent trends,  China's public health programs.
however. Since the early 1990s, mortality rates have  * The shift to a more market-oriented economy has
increased in many provinces, particularly among infants  changed environmental and behavioral risk factors, thus
and children under age five. And health status and  diversifying the types of disease across regions.
health-related process indicators have improved more  Hossain suggests strategies for mitigating China's
slowly than in the mid-1980s.  current  and emerging health problems.
This paper - a product of the Rural and Social Development Division, China and Mongolia Department - appeared in
an earlier version as chapter 2 of World Bank, "China: Social Sector Expenditure Review, 1996," China and Mongolia
Department, Washington, D.C.,  1996. Copies of the paper are available free from the World Bank, 1818 H Street NW,
Washington,  DC 20433.  Please contact  Clydina Anbiah, room T7-015,  telephone 202-458-1275,  fax 202-522-1778,
Internet address shossain@worldbank.org. August 1997.  (35 pages)
The Policy Research Working Paper Series disseminates the findings of  work in  progress  to  encourage the exchange of  ideas about
development issues.  An objective of the series  is to get the findings out quickly, even if the presentations are less than fully  polished. The
papers carry the names of the authors and should be cited accordingly. The findings, interpretations, and conclusions expressed in this
paper are entirely those of the authors. They do not necessarily  represent the view of the World Bank, its Executive Directors, or the
countries they represent.
Produced by the Policy Research Dissemination CenterTackling Health Transition In China
by
Shaikh I. Hossain
An  earlier version  of  this  paper appeared  in  Chapter 2  in,"China: Social  Sector Expenditure
Review,  1996". I am grateful to  Jere Behrman, Jagadish Upadhyay and Nicholas Prescott for
helpful comments. Comments from participants in a seminar held in Beijing are also appreciated.2
Introduction
Over  the  period  of  three  decades,  China  has  made  commendable  strides  towards
improving the health status of its population.  Between 1965 and  1995, China's  infant mortality
rate declined from 90 per 1,000 live births to 36, during the same period, life expectancy at birth
rose from 55 to 69 years, and maternal mortality rate fell from 26 to 15 per 100,000 deliveries.
When compared with similar Asian economies, China's  performance has also been favorable as
its infant mortality rate for example was less than one-half of the rate predicted for its income
level (fig 1). Similarly, life expectancy at birth was higher than many Asian comparators (fig 2).
These  impressive gains  in  health  status  have been the  direct products  of the  government's
political  resolve and  imperative in the early  1970s, when the proliferation  of public  financed
community and preventive health programs rapidly expanded access to basic health  care and
broadened its coverage.
However, these positive indicators conceal more recent trends.  Since the early  1990s,
mortality  rates  have  increased  in  many  provinces,  particularly  among  infants  and  children
younger than age 5.  Moreover, the countries whose mortality rates among these two groups were
already low in 1965--Malaysia, South Korea, Thailand and Sri Lanka--continued to show larger
percentage declines in these indicators than did China. Likewise, these countries have showed
larger percentage gains in average life expectancy and they have made greater progress in such
process indicators as coverage for immunization and births attended by trained personnel (Annex
1, Table 1). In China itself, improvements in health status and health- related process indicators
have  been  slower  than  similar  advances  made  in  the mid-1980s.  What  accounts  for  these
relatively stagnant and sometimes deteriorating health indicators, and what strategies should be
designed to address them as China enters 21st century? Overall, as this paper argues, the recent
erosion in gains stems from three factors. One, changes in government financing for the health
sector have created greater inequity, inefficiencies and raised the costs of medical treatment.
Two, the major  contributors to burden of disease have changed from maternal and  infectious
toward non-communicable diseases (NCD) and injuries, the prevention of which has not been a
traditional part of public health programs (PHP), and three the shift to  a more market oriented
economy has changed environmental and behavioral risk factors, thus diversifying the types of
disease across regions.
The paper has three  sections.  In section I, the current problems in  health  sector are
discussed,  while section II presents  emerging health problems of China and the final  section
provides strategic directions to mitigate both current and emerging health problems of China.Figure 1
Relationship  Between  Infant Mortality Rate  and GNP  per capita, 1994
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Relationship  Between  Life Expectancy  at Birth and  GNP  per capita,  1994
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Current Problems
Equity
Regressive Public Health Expenditures: The figure 3 shows that public spending was
pro-poor in  1980s, but has become increasingly regressive in the early  1990s--that greater
health expenditures are made in richer provinces. A more instructive finding is that income and
vital health indicators appear to have played a considerable role in budgeting decisions. Poor
provinces, including Henan, Guizhou, Yunnan, and Jiangxi, in which infant mortality rates are
higher than the national average, received meager budgetary resources and spent less. Contrary
to  pro-health risk targeting, poor and high infant mortality provinces--Hunan, Sichuan, and
Guangxi--received considerably low health budgetary outlays. Chief outliers are Shangdong,
Zhejiang, Liaoning, Tianjin, Beijing, and Shanghai, which have high per capita income, a low
infant mortality rate, and high per capita health spending (fig 4).
During the same period, despite a rise in real government health spending, its fiscal
effort for health has reduced, as evidenced by a steady decline in its spending as a percentage of
GNP from  0.77 to  0.45.  If the  average spending levels in  similar Asian  economies are
considered, then the fiscal effort for health in China is weaker (Table 2, Annex).  Exacerbating
this trend is the elimnination  of communal agriculture in the 1980s which dismantled the rural
cooperative medical system, and those who had been covered under this scheme have been
forced to pay for public health services. The growing share of patient fees and corresponding
decline in the share of rural cooperative to total health cost attest to this fact (fig 5). To a large
extent these episodes, as demonstrated below, gradually led to unequal access to health services
across the wealthy and poor, and between the insured and uninsured, and created widening
disparity in the health status of Chinese population.
Unequal Access:  Table  1 presents a  summary of the average number of inpatient and
outpatient visits by province, ranked by per capita income from poor to rich. The usage figures
indicate how public health service has been targeted. They show that the redistributive, or target,
impact of public health services was highest for users in the poorest provinces. In 1980, the average
number  of  inpatient  and  outpatient visits  were  highest  among the  two  poorest  quintiles  of
provinces, but these indicators are at odds with  an apparent reduction in usage  among poorer
provinces in 1993. The elimination of the rural cooperative health scheme and the introduction of
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Table 1: Annual Average Number of inpatient and Outpatient Visits
in Provinces by Quintiles Per Capita Income
Quintiles of Per
Capita Income  1980  1993
in Provinces  Inpatient  Outpatient Inpatient Outpatient
Poorest  I  2.9  3.7  1.8  2.8
II  2.6  3.5  1.7  2.7
III  2.7  3.4  1.9  2.4
IV  2.2  2.8  2.1  2.5
Richest  V  1.8  2.5  1.6  2.2
Source:  Staff Estimates from MOPH data.
Indeed, according to the 1993 National Health Survey (NHS), utilization varies positively
with household  income per  capita. Province-wide data indicate greater under-use of  service in
poorer provinces is associated with economic reasons, and vice versa.  Of total households, 58.8
percent in rural areas and 39.8 percent in urban areas do not use public health facilities due to
economic difficulties. Another factor is the deterioration in quality of public health services due to
the  reduced  public  spending  since  the  mid-1980s.  The  emergence  of  private  sector  and
liberalization of pharnaceutical  sales permitted users, particularly the rich, to move away from
public sector to seek costly and perhaps better quality private health care providers. This is partly
substantiated by the 1993 NHS. Of total households 11 percent in urban areas and  13 percent in
rural areas did not seek public health provider due to poor quality, and about 7 percent used private
health clinics but mostly in big cities and urban areas. A third factor may be the declining age-
specific morbidity rates, requiring fewer visits to  health facilities. But, age and gender-specific
mortality and morbidity rates have shifted from infectious to  more NCD and injuries, and not
declined dramatically to warrant such marked reduction in the utilization of health services. This
overall decline in public inpatient and outpatient utilization in poorer provinces indicates that the
redistributive impact of public health expenditures is increasingly becoming less favorable.
Disparity in the Health Status:  Table 2 displays the percentage change in two health
outcomes and coverage of three public health services by provinces, ranked by per capita income
from poor to rich.  Overall, for the period of 1983-93, disparity in health outcomes--both infant
and maternal mortality rates-- has widened, as mortality declined at a faster rate in the wealthiest
provinces like Zhejiang, Liaoning, Guangdong (quintile V) than in poorest provinces like Anhui,
Henan and Sichuwan (quintile I). Likewise, except richest provinces in quintile V,  public health
services like coverage of safewater and  sanitation generally varied directly with income, that is,
the richer the province, the wider the coverage. Thus, except for three shots of diphtheria-
pertusis-tetanus (DPT3) immunization, the progressivity in the access to two basic public health
services has diminished over time.8
Table 2: Percent Change in Health Indicators by Provinces, 1983-93
(Provinces ranked by per capita income)
Percent Change
Public  Infant  Maternal  _Coverage  of
Quintile  Health  Mortality  Mortality  DPT3  Sanitation  Safewater
of  Spending  Rate  Rate
Provinces
Poorest  I  93  -4.1  -4.3  68.8  58.6  89.1
II  77  -21.8  -4.4  58.9  85.4  90.2
III  69  -20.3  -10.7  50.2  77.4  59.9
IV  65  -30.1  -17.3  67.1  77.3  73.1
Richest  V  58  -32.5  -18.3  57.3  38.2  35.4
Source:  Staff Estimates from MOH data.
Costs and Quality:
The average private out-of-pocket costs per visit to public health services vary widely across
quintiles. Private expenditures on health care are shown in Table 3, ranked according to quintiles,
from poor to rich in urban areas. Although the wealthiest households pay larger absolute amounts
on medical items, as a proportion to non-food household spending, the poorest households spend
about 1.5 times more on medical care than do richer households. Of total non-food expenditure,
drugs and medicine consume about 3 times more among the poorest quintile than among the top
quintile. User fees-non-food expenditure ratio--a measure of affordability--is much larger for the
poorest 20 percent (2%) than for the richest 20 percent (0.60%). The top quintiles spend more on
other category which mainly comprises charges for physician's home visits.
One indirect indication of quality gap is the difference in private expenditures on medical care
across quintiles of household income for the same level of services. According to the findings in
Table  3  the  top  quintile pay  more  in  absolute  amounts and  buy  better  quality, particularly
instruments and drugs. Another indicator is the quality of medical attention received by the low-
income population who use public health facilities. The 1993 NHS suggests that the poor are more
likely to use Township medical centers when sick, but the probability of being treated by qualified
doctor is less than 20 percent. Whereas, the rich are more likely to seek treatment in hospitals where
the probability of consulting trained doctor is more than 60 percent. A third indicator is the paucity
of  qualified medical personnel in  poorer provinces which  exacerbates the  quality  of medical
attention. The calculation of relative medical personnel ratio (RPR) in  Table 4  shows a clear
undersupply of qualified doctors in poorer provinces and an oversupply of such personnel in richer
provinces.9
Table3: Affordability  :Per Capita  Household  Expenditures  on Medical  and Health  Care, 1992
(As  percentage  of Non-foodper  capita  expenditure)
Quintiles  of householdper  capita  income  Expenditure  T-ratio
I  II  III  IV  V  Elasticity
Instrument  0.04  0.04  0.31  0.41  0.44  0.85  1.04
Primaryhealthcare  0.96  0.11  0.12  0.14  0.13  1.45  1.93
Drugs  5.65  4.23  4.08  3.68  2.91  8.11  4.56
Herbal  medicine  0.47  0.42  0.44  0.45  0.50  6.63  2.87
Service  charges  2.05  0.92  0.62  0.76  0.60  1.15  0.77
Othera  0.11  0.08  0.09  0.10  1.05  0.94  1.23
Total  9.28  5.81  5.66  5.54  5.63
a. Home  visits.
Source: SSB:  Urban  Income  Expenditure  Survey,  1992.
Table 4:  Quality -Medical Personnel Input Mixes by Province (1994)
Province
by quintile  Relative Personnel Ratio(RPI)
ofper capita  Special  Asst.
income  Doctor  Nurse  Doctor  Nurse  Midwife
I  0.81  0.77  0.82  0.67  0.74
II  0.94  0.95  1.07  0.90  0.61
III  1.34  1.23  1.34  1.26  1.05
IV  0.86  1.15  1.24  1.16  1.40
V  1.90  2.38  1.76  2.48  1.33
RPR= (Provincial Staff/Provincial Population)/(National  StafflNational  Population)
RPR exceeding one indicates oversupply and less  ihan  one indicates undersupply of  medical
personnel.
Source: Table 9 (Annex).10
Efficiency:
Greater Inefficiency: In addition to equity problems, China is getting less incremental
health  improvement as  a  return on  its  expenditures than  in the  mid-1980s, thus  creating
efficiency problems. Once again, Table 2  shows how the maximum outcomes--percentage
reductions  in  infant  and  maternal  mortality  rates--have  been  achieved  with  minimum
percentage increments in public health expenditure.  It is clear that the greater the percentage
increase in public health spending the  smaller the reduction in mortality rates in the poorest
provinces (quintile I) than in the wealthiest provinces (quintile V) between 1982 and  1993.
Figure 6 shows that most of the wealthy provinces are significant (negative) outliers, having
lower infant mortality rates predicted for its government health spending.  When regression is
done with provincial data, the impact of government health spending on reducing mortality
rates in 1982 was greater in poorer provinces than in richer provinces. Conversely, in 1993, a
somewhat reduced effect of government health spending on health status was found in poorer
provinces than in wealthy provinces (Technical Annex A).
Relative Effects of Public Policies on Health Status.  Before eliciting future strategies in
the final section, it would be useful to assess the effects of several public health interventions on
the overall health status of Chinese population. For more than three decades, China has made
remarkable stride in improving the health status of its population. Given the extent of this
progress, it is,  important to examine whether the improvement in health outcomes can be linked
to specific components of public policy or, as is also possible, whether the achievement is due
mainly  to  gains  in  overall income overtime. Thus, this  section posits to  what  extent  can
particular government policies such as public expenditure on health, access to various public
health services improve the health status of the population?
Regressions are used to assess the impacts of changing government policies and income
levels on infant mortality rates and life expectancy at birth. The data used are a time-series of 1983-
93 from cross-section of 29 provinces in China. To isolate the relative effects of each determinant
of health improvement, three different econometric procedures are used, and Table 5 presents the
results'.The empirical results indicate the importance of income, public health expenditures,
sanitation and DPT3. Income is consistently the most important variable in reducing mortality. The
OLS estimates show that provinces with coverage of safewater and sanitation facilities have had
low infant mortality rates. The positive coefficient on public health expenditures reflects that more
money is being spent in those provinces where infant mortality rates are high. The impact of such
expenditures is manifested in the fixed and random effect columns. Indeed, the results show that
overtime, greater allocation of government resources did have a favorable impact in reducing infant
deaths, suggesting that higher expenditure, generally synonymous with expanded supply of drugs,
consumables, and equipment, can be effective in improving health status.
I  To disentangle  the relative impacts of income growth and public policy variables (expenditures,
sanitation,  safewater,  DPT3)  on infant  mortality  rates and gains in life expectancy  at birth, three methods
are used, simple OLS without  provincial  dummies;  a fixed effect model with provincial  dummies, and
random  effect  with generalized  least  squares  (GLS).Figure 6
Relationship Between  Infant Mortality Rate  and Health Expenditure,  1993
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Table  5: Regression  Results  of Public  Policies  on Health  Status
Dependent  Variable:  Infant  Mortality  Rate
Right hand  OLS  Fixed  Random
side variables  Estimates  Effects  Effects
log Income  per capita  -0.688*  0.049  -0.509*
(9.828)  (1.28)  (-6.97)
log  per capita  Health  0.249  -0.114*  -0.531  *
Expenditure  (4.44)  (-2.20)  (-8.16)
Safe  water  -0.234*  .052  NC
(-4.178)  (1.3)
Sanitation  -.154  -0.286*  -0.200
(-1.811)  (-3.404)  (-0.83)
DPT3  0.134  -0.259*  -0.242*
(1.13)  (-2.192)  (-3.15)
N  348  348  348
Adj.  R 2 0.55  0.96  0.20
*Indicates  significant  at 5% confidence  level.  Numbers  in parentheses  are  the t-statistics.
Immunization  and sanitation  clearly have discernible  independent  irnpact on improving
health  status  in all empirical  specifications.  The DPT3  variable  measures  the percentage  of one-year
old children receiving  a full series (3-shots)  of diphtheria,  pertussis  and tetanus immunizations.
Results  also show  that the efficacy  of the logistical  support  of health  system  because  the completion
of three-shot sequence requires a  fully organized personnel who interact routinely with the
population.  Likewise, sanitation  needs community  support and better coordination  with health
personnel.  Interventions  in sanitation  and immunization,  spearheaded  by commune  health system  in
China  have  attained  remarkable  successes  to combat  infectious  diseases  and reduce  infant  deaths.
But when an interactive  term between income and government  health expenditure  is
included  in a separate  regression,  a somewhat  interesting  result emerges  (Technical  Annex  A).  In
this case  the coefficient  on the expenditure  variable  by itself is the first  derivative  if income  is zero
that tends to counterbalance  the direct effect  of expenditure  on infant mortality  given a negative
coefficient  estimate on the interaction.  It is difficult to disentangle  autonomous  government
spending  from implicit  subsidy  associated  with the presence  of more doctors  and therefore  induced
by more demand and income. Other than income,  such public health services  as santiation  and
DPT3 still show strong effects  on improved  health status.  At least this is consistent  across all
regression  estimates,  and firther justifies  improved  access  to these basic services  among  rural and
poor  people.13
Finally, the impact of government policy on health status is assessed with regression
analysis using the cross-sectional country level data. In each country, a panel of cross-section
(provinces or regions) and different time-series data were utilized. The results in several studies
indicate uniformly favorable impact of immunization and water supply on health status in the
Philippines, Malaysia and Viet Nam, while sanitation and immunization are more effective in
China. Poor country  such as Viet Nam faced stricter economic  constraints  than others in the sample
during the period under review, and so improved health status is a result of rising income growth
than public health spending. The dissimilar effects of public health spending in Viet Nam also
reflects greater importance of other health promoting interventions  for reducing infant deaths in a
period of deteriorating health infrastructure,  high incidence of infectious and water-borne  diseases
and poor quality of services.  (See Technical  Annex A).
Emerging  Problems
Health Transition:
China is now completing its  demographic transition from high  fertility and mortality
rates to  low ones. The demographic transition has profoundly influenced the age structure of
population and the cause of mortality which has set the stage for epidemiological change. As the
population continues to age, the relative frequency of various causes of death changes, causing
more chronic diseases to occur among the older population and fewer infectious diseases among
the younger population. Figure 7 illustrates that the proportion of older population will rise from
9.5 percent in 1995 to 16 percent in 2020, and the proportion of deaths among this age group will
increase from 55 to 65 percent because mortality rates from infectious and childhood diseases are
decreasing disproportionately during the  same period. By way  of illustration, China's  close
Asian comparators--South Korea, Malaysia, and Thailand--will generally experience  similar
shifts in the age structure of their population and age pattern of mortality.
Changing Risk Factors
Lifestyle choices for example, cigarette consumption, alcohol intake, as well as such factors as
urbanization, environmental pollution, and differences in access to health services are changing the
exposure of China's population to the risks of different diseases. As a result, the  pattern of disease is
becoming  more  diverse across the  provinces and  socio-economic groups. Prior  to  the  health
transition, fewer diseases were responsible for the majority of deaths; now, with progress in the fight
against immunizable diseases and diarrhea, the pattern of disease is increasingly being characterized
by  a  "dilated-polarized epidemiological" regime  in which  infectious diseases  and  malnutrition
coexist with non-communicable  diseases and injuries both across rural and urban areas, and among
poor and non-poor regions (Table 3, Annex).
Ironically, this  growing diversity has  come in  the face of  several successful public  health
interventions.  New diseases have emerged and have resurfaced old ones.2  Although the prevalence  of
sexually  transmitted  diseases (STD) and Acquired  Immunodeficiency  Syndrome  (AIDS) is not yet
2  For example,  AIDS  is a new disease,  but this has brought  back  tuberculosis,  and malaria  has become
widespread  with the diminished  vector  control  programs  in several  provinces  in China.Figure 7
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significant,  incidence  rates are rising each year, with a real potential  for explosive growth.  For
example,  the incidence  of STD  has risen  to more  than 13  percent  in 1994, the HIV-  positive  cases  have
now reached  1,600,  including  about  40 cases  of AIDS,  and malaria  has reappeared  with an incidence  of
5.6 percent. The incidence  of other communicable  diseases  like viral hepatitis  and dysentery  have is
also high (Table  4, Annex).
Overall,  when the total disease  burden--the  sum  of all disability  adjusted  life years lost (DALY)  by
the population  in China--is  computed  in Table  5 (Annex)  , it is clear that the main contributors  to the
burden  of diseases  will dramatically  shift  from communicable  to NCD  and injuries  in the 21st century.
The NCD will account  for the bulk of the disease  burden--76  percent of total DALY lost in 2020--
followed by injuries (17%) and noncommunicable  diseases (6%).  Of total DALY lost, malignant
neoplasm  and cardiovascular  diseases  will steal  more  than  a half of healthy  life years  in China. Similar
dramatic  increase  in DALY lost will occur from chronic  obstructive  pulmonary  (COPD)  from only 4
percent  in 1993  to nearly  16 percent  in 2020  due to smoking  the single  most important  factor  and other
new  health  risks  including  air pollution.
III. Strategic Directions For 21st Century
The analysis shows that composite  changes in demographic,  epidemiological,  and risk
factors  imply a growing  health burden  from NCD and injuries  and a higher adult mortality  risks
which in turn will change  the volume and composition  of the demand for referral and curative
health services. Since the prevention  of these diseases  has not been a part of primary health
program until recently,  they will pose new challenges  in the design and management  of public
health services in the future. In addition,  by emphasizing  revenue-generating  curative services
rather than  basic  preventive health care,  economic reforms have  created inequities and
inefficiencies  in the health system, along with rising medical costs. As China enters the 21st
century,  the following strategies  will be required  to respond  to the new health challenges  and the
emerging  threat  of diseases.
Resolving current problems:
Strengthening Public Health Programs.  China's public health program (PUP), once the
envy of many developing countries, has now begun to exhibit inequities and inefficiencies.  The
main challenge is how to give the uninsured and the poor better access to affordable PUP without
affecting the quality of services. Based on the assessment of the burden of main diseases and cost-
effective public health and essential clinical interventions. Box 1 proposes a basic health service
package that consists of essential PHP, and minimum clinical services. These two packages are
designed to meet externalities to which those at risk and in poverty are most exposed. Together,
essential PHP and minimum clinical package would reduce the share of illness in terms of disease
burden averted from 28 percent in 1993 to roughly 39 percent in 2020. These two packages can be
delivered at a per capita cost about US$ 10 which would increase approximately to US$ 60 in 2020,
given changes in epidemiology, age structure of the population and the costs in medical supplies.
As an  useful guide for China, per  capita costs of combined packages in such middle-income16
countries as South Korea, Turkey, Costa Rica, South Africa  vary from US$20 to a maximum of
US$ 350.3
BOX I
(1)  (2)  (3)
Essential Public  Minimum  Discretionary
Health Package  Clinical Package  Clinical Package
1993
Burden of Disease
Averted (%)  14.8  14.0
Per capita cost (US$)  3.7  6.3  30-45
(Annual)
2020
BOD Averted (%)  18.2  25.1
Per capita cost (US$)  8.8  20.2
(Annual)
Note: Major interventions under each package are outlined in Technical Annex A
Epidemiological and demographic data are used to calculate the benefits as disability adjusted
life years saved (DALY) from interventions under essential PHP and minimum clinical package.
The estimates show that interventions under (1) and (2) above packages would reduce the burden
of  diseases including most of the "remaining" and "emerging" diseases (Table 3 Annex 2) by
about 28 percent in terms of total DALY saved observed in 1993. The itemized costs of specific
interventions were provided by the MOH and Chinese Academy of Preventive Medicine
(CAPM) and estimated from project preparation activities. By applying similar procedure, a
rough projection shows that essential PHP and minimum clinical interventions would reduce
BOD by 43 percent in 2020, an overall gain by 15 percent.  If  legislative measures, outside the
purview of the  PHP, are implemented,  further reduction in the BOD from injuries and COPD
would be possible.
For methodologies, see C.J.L Murray and A.D Lopez in their report, "Global Burden of Disease"
Bulletin of the World Health Organization, 1990, 72 (3).
The government should increase its spending level to meet these service requirements not
only because such interventions are the most cost-effective but also because of a salutary impact of
government expenditure on improving health status of Chinese population, as revealed by our
regression estimates with panel data. Moreover, resource requirements are modest compared with
3  These figures capture roughly 2 to 7 percent of those countries GNP. See World Development
Report 1993, World Bank, Oxford.17
overall health spending. Additional resources for targeting the uninsured poor can come from an
extension in  the coverage of social insurance (GIS and LIS), the passage of a basic package in
social as well  as future private insurance policies, and selective increases in  user fees for the
uninsured wealthy.  The  discretionary clinical package  can be  financed  from  user  fees  and
insurance and public funds should be used only for truly poor and indigent patients.
Redeploying Medical Personnel.  Alternative mixes of labor inputs are influenced by the
allocation of public spending which in turn will influence future health outcomes. In China, indices
of labor input for western medical treatments show an inegalitarian allocation across provinces.
Poor provinces are deprived of more qualified medical staff. Table 4 showed the distribution of
more qualified health personnel (doctors, assistant doctors) and  less qualified health personnel
(specialized nurses, nurses, and midwives). Computed on the basis of relative personnel ratios
(RPR) the richest quintile of provinces-- Beijing, Shanghai, Guangdong, Zhejiang, Tianjin and
Liaoning clearly have an oversupply of all medical staff but particularly of more qualified staff, as
the  value of  RPR  far  exceeds unity. Conversely, the poorest  quintile of provinces--Guizhou,
Xinjiang, Anhui,  Henan,  Guangxi and  Sichuan (Annex Table  9)--have an  undersupply of  all
medical staff including more qualified personnel. Other less disadvantaged provinces in the second
quintile--Jiangxi, Yunan, Shannxi, Hunan, and Tibet--also have an undersupply of more qualified
medical personnel especially doctors.
Besides their impacts on health outcomes, the different mixes of health personnel will have
important underpinnings on cost efficiency. In provinces with high morbidity and mortality rates
from infectious and communicable diseases, redeploying the personnel mix toward more preventive
health services staff like nurses and midwives can generate further cost savings. To  attract and
retain more qualified staff in poorer provinces, the government should also provide such incentives
as housing, bonuses, education for dependents, and better posting after service in rural areas. To
minimize future imbalance in labor input mixes, another powerful policy instrument is to upgrade
training  and  retraining for  less qualified health personnel and  then  substitute them  for  more
qualified  staff  where  feasible.  To  implement these  policies, the  government  should  ease  its
currently rigid controls on remuneration to  make it more amenable to  local needs.  However,
whether the local or the central government should be given authority to choose the structure of
such benefit package remains an open question.
Targeting of resources:  One implication of reduced government health financing is that
the poor has  suffered higher morbidity and mortality. Among the poorest  quarter of the rural
population,  infant  deaths  are  3.5  times  greater  than  among  city  dwellers  (NHS  1991).
Compounding this inequity is the wide disparity in the distribution of provincial government health
expenditures particularly  in the  past  few  years. Further  econometric analysis with  1993 data
indicates that province-level public spending on health responds more strongly to changes in GDP
in  high-income provinces than  in  low-income provinces. Moreover,  a  one  percent  growth  in
provincial income is associated with much greater increase in government health expenditure in
richer provinces than in poorer ones. These results are disturbing, since they imply that even with
equitable growth in income across provinces--an unlikely prospect--the distribution of provincial
government expenditure on health will become more unequal. If economic growth in the province
alone is less likely to reduce the imbalance in provincial health expenditures, a strong case can be18
made for the central government to target an increasing share of central government resources to
the poorest provinces.
While  a larger proportionate increase in  government spending on health in  the poorer
provinces than in the richer provinces will clearly promote equity, its relative effect on efficiency is
not immediately obvious. Indeed, the latter depends much on the marginal impact of increased
public health expenditure on health outcomes. Table 5 reports the impact of a 1,000 yuan increase
on infant mortality rates by quintile of provinces. An increase of 1,000 yuan in per capita provincial
government health spending in high-income provinces is associated with drops in infant mortality
of only 0.12 percent. Conversely, similar increase in per capita health expenditure leads to a decline
of infant mortality by 3.04 percent in poorer provinces. Thus, a  1,000 yuan  increase in health
spending yields much faster decline in infant and maternal mortality in poorest provinces. Because
poorest provinces account for more than 30 percent of the total population of China, a strategy of
redistribution of  central government  health  expenditure from  richer to  poorer  provinces will
generate a larger overall decline in infant mortality, and as such will improve the overall efficiency
of public health financing.
Table 5: Impact of a 1,000  yuan increase in provincial government
health expenditure  on infant mortality, 1993
Quintile of  Percentage  Infant  Maternal
Provinces  ofpopulation  mortality  mortality
I  30.8  -3.04  -1.01
lI  15.6  -2.45  -0.67
lII  17.2  -1.05  -0.44
IV  24.2  -0.43  -0.23
V  13.9  -0.12  -0.03
Source:  Staff estimate from MOPH data.
Restructuring  User Fees.  The combination of recent worsening  income distribution,
reduced government health spending and price decontrols (resulting in higher prices for health care
and other consumable) reduced utilization of health services, consequently worsening their health
status particularly in poor provinces. The government is concerned about cushioning the poorest of
the poor from further higher health costs stemming from changing age pattern of diseases and
greater cost  recovery in  public health  sector. Indeed, better targeting of public expenditure to
improve access of the poorest to health facilities would depend on two policy instruments: reducing
user costs associated with treatment and drugs, and improving the quality of care for those who
actually gain access.
4The  implied  GDP elasticity  of provincial  government  health expenditures  varies  from a low of -0.098
for Guizhou,  the poorest  province  in China,  to a high of 2.56 for Shanghai,  the richest  province.19
A more effective mechanism should be devised to protect the poor from user fee increases;
the current mechanism in place in China to  exempt the indigent from fees is not working. As
household expenditure data showed there is a weak relationship between household income and the
average  price paid  for treatment,  that  is, households  in the  bottom  income  quintile  spend a
disproportionately high share (13 percent) of their total health expenditure on one annual visit. They
also spend more on drugs, which are generally not subsidized. Of total private health spending, the
poorest households pay 77 percent on drugs compared with 68 percent by the richest quintile. Thus,
the burden of paying for service charge and drugs is higher among the poor than the better off.
Since this  disproportionate burden prevents the poor  from  using public  health facilities, then
improving access for them may require selective price reductions for essential services; the poorest
hard-to-reach group  should be  exempt  from paying fees, which  may be  compensated for  by
increases in public spending and other insurance fees. This needs an appropriate pricing policy that
differentiates prices by the income of users
Finally, improving the quality of public health services  would enhance utilization. One indicator
of the quality gap is the variation across income groups in the amount of household expenditure on
public health, but another indicator, available from the 1993 NHS, is that 15 percent of households
do not use public health facilities due to the lack of beds (4.1%) and the absence of proper services
and treatment (11.3%). Interprovincial variation is even wider. Another indicator is that the poor are
less likely than the better-off to receive treatment by qualified and trained doctors when they are
sick. Spending on medical equipment, supplies, drugs, and physical infrastructure in township
health centers and the redeployment of trained personnel in needy areas would considerably
improve the quality of services available to the poor.
Addressing Emerging Problems:
Strengthening the Information. Education and Communication (IEC): The disease burden
in China implies that about two-thirds of premature deaths and disabilities stem from such  risk
factors as excessive smoking, improper diet, alcohol intake, the lack of exercises, environmental
abuse,  or  dangerous  sexual practices. These  factors are  linked  to  the  behavioral choices  of
individuals and  have a  combined  synergistic effect. Discouraging these unhealthy  choices by
individuals is difficult, given the complexity of emotional, intellectual, and social influences that
shape the decisions of population. One viable strategy would be to have the government join with
the private sector to strengthen the IEC network and its efforts to deliver one overriding message--
that eliminating or reducing exposure to risk factors via immunization, maternal weaning, waste
disposal, screening of  treatable diseases, and changes in  life styles  is more effective and  less
expensive than the longer-term secondary treatment. The message should be delivered by the mass
media, communication technologies, post-primary school curriculum, and reinforced by teachers
and community workers.
Passing Legislation:  The findings on  the burden of  diseases clearly suggest that the
government should enact various legislative measures and restrictions to alleviate sufferings from
NCD and injuries in the future. For example, to reduce the risks of obstructive pulmonary disease
which will account for more 14 percent of total DALY lost from NCD by 2020, the government
should place  legislative ban  on  cigarette smoking  in  public  places, and  among the  younger
population, as well as on the advertisement and promotion of any tobacco goods and trademarks.
Together, these measures would gradually reduce morbidity and mortality from smoking-related
diseases. It  should also consider increasing taxes on tobacco as a  disincentive to  smoking, to20
provide additional revenues to be devoted to public health programs. A rough calculation of such
potential is obtained from revenue buoyancy estimates.  The point estimates of revenues from non-
tax, tax, and tobacco tax with respect to local government GDP exceed unity; and a  10 percent
tobacco taxes tend to reduce cigarette consumption by 6 percent; reflecting that this levy is very
buoyant revenue instrument and consumption  deterrent.  Other legislation and/or restrictions should
targeted to reducing the risks of disability  or death from injury, which will steal 16 percent of total
DALY lost in 2020, up from the 10 percent figure in 1993. Transport  accidents in particular should
be targeted, since they account for more than a half of total DALY lost due to injury. Government
transportation  policy should seek to improve traffic safety by upgrading  road design, traffic signals,
and speed limits, and to modify drivers' behavior particularly  with the imposition of  higher fines
for drunk drivers. Although studies on alcohol-related  motor vehicle accidents  and deaths in China
are unavailable  the U.S studies should alert the decision-  makers of China.s
Reforming Urban Health Insurance.  The urban health insurance schemes  i.e GIS and LIS
are providing inadequate coverage and  face rising  costs. Because, schemes cover only the
employment-based  population, capturing only 14 percent of the total population of China. Their
costs are escalating in real terms due to growing number of claims, and they promise to rise in the
future, as the population ages and the number of claims for curative care increases (Annex Table
7).  "Moral hazard" factors also escalate costs, since they create incentives  for health providers to
offer more care than patients actually need and to overprescribe  medication and tests. These profit
earning opportunities may  lead to  an  overconsumption of  newly  developed and  expensive
technologies as a substitute for less expensive  diagnostic tests and surgical procedures.  To enhance
coverage and contain costs, the government should  pursue four options:  centralize  the management
of health insurance, extend  GIS and LIS coverage, and redesign benefit packages including
prepayment  system.
Centralized management would  create  larger risk  pools  and  provide  administrative
economies  of scale, and capture employees who risk losing coverage as their SOEs face bankruptcy
or merger under the SOE reform. A combined pool would also give local governments greater
bargaining  power for negotiating  contracts on capitation  payments.  But implementation  will require
vigorous inter-agency  coordination  because comparatively  young LIS beneficiaries  would naturally
oppose pooling their risks with their comparatively  old GIS counterparts.  In this respect, it is worth
highlighting  the experience  of Jiujiang and Zhenjiang  cities, which have combined  the GIS and LIS
systems in order to smooth the cost of health services  over time by distributing  it equally across the
beneficiaries.
Coverage under the GIS and LIS could be broadened, first by including the dependents of
beneficiaries and then by covering all labor in the formal and informal sectors. But the experience
of Shenzhen health insurance scheme suggests that private and joint venture companies will not
readily participate in this social health insurance scheme. Here, an alternative  policy option would
be to make hospitals liable for all overspending  on the capitation payments (introduced in 1991),
forcing  them to invest and create trust funds with profits and unused capitation money. This option
would gradually elimninate  the 50 percent government  contribution  to such over-spending.  The free-
up resources  would give additional  leverage  for financing  the essential  package for the uninsured.
5  In the U.S, more  than 50 percent  of all motor  vehicle  related  deaths  are alcohol-related.  See for
example,  Anon 1990"  Alcohol-related  Traffic  Fatalities:  United  States  1982-89"  Morbidity  and
Mortality  Weekly  Report 39.21
To contain sosts further, the government should consider redesigning  the clinical services
package covered by GIS and LIS, as well as implementing  a prepayment scheme for health care
providers. The redesigned package could consist of several parts, based on the degree of cost-
effectiveness (Technical  Annex A). Part A would include vaccinations,  pre and post-natal care that
can be reimbursed  at full cost, Part B would be reimbursed  at 80 percent of cost, and Part C would
contain interventions  that would be kept at the current level of underfinancing,  with premium rates
raised with inflation. This more flexible system can be adopted to and the level of copayment  can
be reconfigured  according to the social insurance's fund position.  Normally,  providers will respond
more to parts A and B than to part C, thereby improving the allocative efficiency of financing.
Providers can collect fees from patients to cover the gap between GIS and LIS reimbursement  and
the full costs of the parts B and C interventions.  Elsewhere  among middle-income  countries, such
flexibility is being proposed in Brazil and Mexico. 6
Strengthening the Rural Health Insurance: China's rural risk-coverage programs have
weakened significantly  due to the dismantling  of the RCM insurance in the early 1980s. The rural
population  now relies on government  subsidy and their own resources. To remedy this problem one
alternative would be to reintroduce  the rural community  health insurance scheme with financing
from household income, village social welfare funds and local government budget. Indeed, the
Sichuan Rural Health Insurance  Experiment  should be replicated  with special emphasis on a local
package in the proposed essential PHP and minimum clinical interventions (Technical Annex A)
but can be reconfigured differently  to a diversified disease pattern and diverse population. Many
villages have started to reestablish such insurance  programs and they currently cover more than 10
percent of total rural population.  Greater efficiency can be built into the scheme by allowing
households to purchase an annual health card that would entitle the purchaser  to a fixed number of
treatmnents  for curative care and an unlimited number of visits for  such preventive services as
maternal and child health care and inmmunizations.  The card  would be priced at less than the armual
average household expenditure.
Developing  Private Insurance: As the economy continues to grow, people may  need
supplementary insurance or individuals not covered by social insurance would like to purchase
private insurance policies. The government  should encourage the development  of private insurance
thus  promoting greater diversity and competition in the supply of health services. In several
middle-income  Latin American countries  the absence  of competition in the provision of health care
inhibited corruption and inefficiencies  in their social security schemes, and even in countries like
Korea and Japan, several semi-independent  insurance firms compete over a single large insurance
corporation. In China, however, specific legislation  should be enacted to guard against abuse and
forbid exclusion of pre-existing medical conditions. Until the new legislation in 1996, the U.S
suffered from such problems,  creating  gaps in coverage and cost escalations. Since social insurance
is already in place implementing  safeguards  over future private insurance  should not be too difficult
for China.
6See  World  Bank,"Brazil:  Health  Sector  Reform  Project"  (1  5522-BR)and  for Mexico  see, FUNSALUD:
"El paquete  universal  de servicios  de salud"  Documento  11, para  el analisis  y la convergencia,  199422
ANNEX
Table 1:  Change  in Health  Indicators  in Selected  Asian  Countries:  (percentage)
Change  (1965-94)_  _Change  (1981-94)
Infant  Under-5  Life  DPT3  BATP  a!
Mortality  Mortality  Expectancy
Rate  Rate  at Birth
Bangladesh  -43  -24  39  700
Bhutan  -26  -23  30
China  -60  -40  24  12  30
India  -53  -50  36  80  35
Indonesia  -58  -52  36  77  37
S. Korea  -80  -70  42  21  67
Lao PDR  -37  -25  24  35  60
Malaysia  -78  -64  32  8  90
Mongolia  -54  -27  33  14  16
Myanmar  -36  -54  29  92
Nepal  -44  -31  18  155  12
Philippines  -44  -40  20  45  16
Papua  New Guinea  -57  -67  36  -15  34
SriLanka  -74  -84  14  33  38
Thailand  -63  -74  28  50  39
Viet Nam  -62  -58  24  29  45
Mean  -54  -49  30
Population  weighted  -50  -51  33
Mean
a/ BATP=  Births  Attended  by Trained  Persons
Source:  Calculated  from World  Bank data base23
TABLE 2:  BASIC  INDICATORS  OF OVERALL  HEALTH DEVELOPMENT,  1993
Life  % Change in
Public Health Expenditure  Mortality Rate  Expectancy  Infant
as a percent of:  (per 1,000)  at Birth  Mortality
Rate
of GNP  public  Infant  Maternal  (Years)  (1965-93)
expenditure
Bangladesh  0.8  4.5  92  3.5  55  -43
Bhutan  1.7  2.6  127  NA  48  -26
China  0.5  2.7  34  0.1  69  -60
India  2.0  6.7  80  2.5  61  -53
Indonesia  1.0  3.8  66  3.3  61  -58
Korea  0.8  2.2  13  0.1  71  -80
Lao PDR  2.8  4.9  125  6.6  50  -37
Malaysia  2.9  6.8  15  0.3  71  -78
Mongolia  3.5  7.9  50  2.6  62  -54
Myanmar  2.1  6.8  72  0.7  60  -36
Nepal  1.2  4.3  101  5.8  53  -44
Philippines  1.2  4.9  51  0.9  64  -44
Papua New  3.6  10.1  61  6.0  54  -57
Guinea
Sri Lanka  1.7  4.5  20  0.3  72  -74
Thailand  1.6  6.1  26  1.0  69  -63
Viet Nam  0.8  3.3  45  1.2  65  -62
Mean  1.6  5.0  62  2.3  62  -54
Population Weighted Mean  56  1.4  65  -50
Source: World Bank data file24
Table 3: Health Problems Affecting Chinese Population
Population (°/O)  Deaths (%)  Existing  Emerging
Age  1995  2020  1995  2020 Problems  Problems
group
0-4  8.8  6.9  8.6  3.1 ARI  Injury






5-14  17.3  13.4  1.5  0.6 Geohelminth  Learning Disability
Micronutrient
Schistosomiasis
15-44  51.3  41.1  12.4  6.2 Malaria  AIDS
Maternal Mortality  Injury
Tuberculosis  STD













Source: World Bank Population Projection,  Staff Estimate from DS Survey, Beijing25
Table  4: China: Ten Major Causes  of Death, 1957-94
1957  1994
Deaths  (%)  Incidence
A. Diseases  Rank  Urban  per  Urban  Rank  Rural
Rank
100,000
Respiratory  disease  1  16.8  3  16  1  25.2
Infectious  2  7.9  9  1.3  8  1.4
Pulmonary  TB  3  7.5  24.8  8  1.5  9  1.7
Digestive  4  7.3  6  4.6  6  1.8
Heart  5  6.6  23  4  14.9  5  4.8
Cerebrovascular  6  5.4  33.8  1  22.1  3  16.3
Cancer  7  5.1  32.2  2  21.8  2  16.5
Nervous  system  8  4.1  13.6  7  1.6  7  1.8
Trauma  9  2.6  5  6.7  4  11.9
Other TB  10  1.9
B. Incidence  of Communicable  Diseases







Hemorrhagic  Fever  5.7
Malaria  5.6
Note: Rural deaths (%) and Incidence  Rates are not available  for 1957
Source:  MOH and CAPM26
Table 5: Burden  of Diseases  in China:  Disability  Adjusted  Life Years  Lost  (DALY)
Disease  As a Percentage  of Total DALY
1993  2020
Communicable  Diseases  21.6  6.2
Hepatitis  10.7  3.6
HIV  0.1  0.2
Polio  0.1  0.5
Measles  1.1  0.8
Tetanus  0.5  0.2
Tuberculosis  8.3  0.9
Pertusis  0.8  0
Diptheria  0.1  0
Non-Communicable  Diseases  68.1  76.4
Malignant  Neoplasm
Stomach  Cancer  9.3  4
Liver  Cancer  14.5  12.2
Lung Cancer  5.9  7.8
Breast  Cancer  1.6  2.5
Cervix  Uteri  Cancer  0.3  0.2
Leukaemia  15.1  14.5
Cardiovascular
Rheum  Heart Disease  0.8  2.6
Ischemic  3.3  6.5
Cerebrovascular  13.4  10.3
COPD  3.9  15.8
Injuries  10.4  17.4
Transport  Accident  4.8  5.3
Poisoning  0.3  0.8
Falls  0.4  1.6
Drowning  1.9  1.8
Drugs  2.3  7.3
Others  0.6  0.6
TOTAL  DALY  100  100
Source:  Staff calculation  from CAPM  surveys27
ANNEX
Table 6: CHINA:  Total  Health  Expenditure
(million Yuan)
Current  Prices  1987  Prices  Percentagg  Share  As
National  National
Year  Public  Private  Total  Public  Private  Total  Public  Private  Public
1983  10686  7153  17839  8271  5536  13807  59.9  40.1  1.8
1984  12248  8591  20839  9970  6993  16963  58.8  41.2  1.8
1985  14309  8867  23176  12921  8007  20928  61.7  38.3  1.7
1986  18116  9612  27728  17138  9093  26231  65.3  34.7  1.9
1987  20844  12789  33633  20844  12789  33633  62.0  38.0  1.8
1988  26556  16716  43272  23711  14925  38636  61.4  38.6  1.9
1989  30886  20422  51308  25111  16603  41714  60.2  39.8  1.9
1990  35814  23798  59612  27132  18029  45161  60.1  39.9  2.0
1991  41047  30435  71482  29173  21631  50805  57.4  42.6  2.0
1992  48690  35850  84540  33077  24355  57432  57.6  42.4  2.0
1993  52076  37801  89877  36673  26620  63294  57.9  42.1  1.9
Average  28297  19276  47573  22184  14962  37146  60.2  39.8  1.9
Note: Public Sector includes central & local govermnents, and SOE expenditures.
Source:  MOPH.28
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Table 7: Sources  of Financing  Total  Health  Expenditure
(Current  Prices,  Million  Yuan)
Domestic  sources
Rural
Government  budget  Insurance  Collective Patient Foreign
Year  Central  Local  GEISe  Labor  Fund  fees  aid  Total
1980  152  3033  668  3725  2110  2944  NA  12632
1981  172  3244  786  3964  2030  3608  NA  13804
1982  214  3761  908  4677  2100  3648  NA  15308
1983  233  4258  1090  5105  1040  6113  NA  17839
1984  286  4898  1269  5795  1230  7361  NA  20839
1985  400  5686  1544  6678  1430  7437  NA  23176
1986  509  6631  1888  9088  1640  7972  NA  27728
1987  534  6551  2221  11538  1940  10819  NA  33633
1988  572  7143  2912  15929  2550  14166  NA  43272
1989  574  7872  3811  18629  2427  17995  NA  51308
1990  563  8286  4434  22531  2609  21189  NA  59612
1991  552  8907  5041  26547  3450  26985  NA  71482
1992  585  10748  5811  31546  4658  31192  NA  84540
1993  623  12403  NA
NA: Not Applicable  under  the Budget  Reporting  System
a. Local govemment  = aggregate  expenditure  of province  + county  + municipality
b. GEIS:  Govemment  Employees  Insurance  System.
Source: MOPH.29
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Table 8:  Uses of Government Health Expenditure (percentage)
Million Yuan  Share
Year  Preventive  Curative  Total  Preventive  Curative  Total
1980  556  1785  2341  23.8  76.2  100
1981  580  1939  2519  23.0  77.0  100
1982  639  2285  2924  21.9  78.1  100
1983  705  2497  3202  22.0  78.0  100
1984  850  2771  3621  23.5  76.5  100
1985  960  3038  3998  24.0  76.0  100
1986  1114  3620  4734  23.5  76.5  100
1987  1142  3586  4728  24.2  75.8  100
1988  1314  3890  5204  25.2  74.8  100
1989  1473  4349  5822  25.3  74.7  100
1990  1620  4759  6379  25.4  74.6  100
1991  1760  5057  6817  25.8  74.2  100
1992  2346  5743  8089  29.0  71.0  100
1993  2857  6356  9213  31.0  69.0  100
Source:  MOPH.30
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Table 9: Relative  Personnel  Ratio by Province  (RPR)'
Special  Assistant
Province  Doctor  Nurse  Doctor  Nurse  Midwife
Guizhou  0.57  0.58  1.16  0.65  0.77
Guangxi  0.67  0.99  0.74  0.75  0.62
Anhui  0.60  0.74  0.78  0.57  1.03
Henan  0.80  0.70  0.68  0.64  0.75
Gansu  1.02  0.84  0.85  0.85  0.43
Sichuan  1.23  0.79  0.77  0.59  0.90
Jiangxi  0.96  0.98  0.73  0.87  0.80
Yunnan  0.75  0.87  1.09  0.78  0.62
Shaanxi  1.38  1.00  1.00  0.92  0.71
Hunan  0.96  0.81  0.73  0.83  0.73
Tibet  1.08  0.82  1.49  0.66  0.23
Ningxia  1.12  1.26  1.41  1.37  0.62
Qinghai  1.48  1.64  1.25  1.09  0.95
Shanxi  1.65  1.07  1.29  1.30  1.12
Inner Mongolia  1.45  1.06  1.91  1.34  1.08
Hubei  1.34  1.34  0.96  1.25  1.56
Hebei  0.95  0.66  0.96  0.81  0.60
Jilin  1.21  1.65  1.67  1.78  1.02
Xinjiang  0.72  1.85  1.93  1.74  1.03
Fujian  0.94  0.67  1.00  1.02  1.92
Heilongjiang  1.21  1.62  1.55  1.56  1.06
Shandong  0.72  0.93  0.68  0.89  1.20
Jiangsu  0.80  1.03  1.15  0.92  1.38
Zhejiang  0.83  0.77  1.16  0.87  1.76
Liaoning  1.22  2.00  1.46  2.16  1.00
Guangdong  0.89  0.73  0.97  1.22  1.02
Tianjin  2.71  2.69  1.09  2.31  1.11
Beijing  2.67  3.73  2.24  3.78  1.02
Shanghai  2.01  2.74  3.03  2.91  2.53
a. RPR=  (Provincial  Staff/Provincial  Population)/(National  Staff/National
Population)
RPR  exceeding  one indicates  oversupply  and less  than one indicates  undersupply
of medical  personnel.
Source:  Staff calculations  from MOH  data31
TECHNICAL ANNEX A
This  section uses  epidemiological, demographic and  socio-economic  data to  calculate the
benefits as disability adjusted life years saved (DALY) from several interventions from public
health care (PHC) and clinical services (CS)  It then examines cost-effectiveness of each major
intervention under PHC and CS. Using such epidemiological data as the average age at onset of
disease or disability, case fatality rates, duration of disability, and the incidence of disease from
Disease Surveillance conducted by  the Chinese Academy of  Preventive  Medicine (CAPM)
Beijing, the total disease burden--the sum of all DALY lost by the population in China in 1993--
is computed first (Table 5, Annex 2).  It is clear that non-communicable diseases (NCD) account
for the bulk of the disease burden--68 percent of total DALY lost--followed by communicable
diseases (22%) and injuries (10%).  Having estimated the loss in DALY, the next step was to
compute the gains in DALY that would be possible under each major intervention in PHC and
CS.  The  data on  costs of specific interventions were obtained through the MOH, CAPM, and
project preparation activities. If specific data on costs were unavailable, the individual costs of
specific interventions were  estimated through the  analysis of  fixed and  variable  costs  that
currently borne out by the national health system and social insurance schemes.
Presented below  is the basic package of health interventions that consists of essential public
health program (PHP) and minimum clinical services (CS) based on cost-effective analyses.  The
cost-effectiveness of each intervention is calculated against program alternatives--that is the cost
and effect of outpatient care in the absence of public health program.  For instance, for a fixed
amount of resources, vaccination against measles and DPT would save  13 and 7 times more
healthy life years, respectively, than would outpatient treatment.  Thus, immunization services
that have few acceptable private alternatives would have a particularly large payoff to the public.
Implemented on a national basis, the package consisting (A) and (B) would reduce about 28
percent of burden of diseases in terms of DALY saved observed in  1993.  Applying similar
technique, a rough projection suggests that the combined package (A) and (B) would reduce the
burden of disease by 43 percent in 2020.7 The package (C) is the least cost-effective and rough
calculation suggests that the DALY gains from interventions under (C) will vary from 10 to  15
percent but costs will be three times higher on average than the packages (A) and (B).
It is worth pointing out here that the basic health care package is based on DALY gains and the
most cost-effective interventions, and can be adapted in each location to respond to province and
local epidemiological conditions.
7 / For details see C.J.L Murray and A.D Lopez, "The Global Burden of Disease"  Bulletin of
the World Health Organization, 1990, 72 (3)32
BASIC HEALTH PACKAGE
A.  Essential Public Health
7j~~~~~~~~~~~~~~;
1)  Children's and school health programs  0  Infectious and parasitic diseases, breastfeeding
2)  Food hygiene  0  Food handling, preparation, disease transmission
3)  Reproductive health  0  Family planning, sexually transmitted diseases
4)  Nutritional education  0  Consumpion of fat, sugar and salt
5)  Cancer  0  Breast, cervix, gastric, skin, prostate
6)  Mental health  0  Depression
7)  Accident prevention  0  Home, school, public areas, workplace
8)  Prevention of addictions  0  Tobacco, alcohol, drugs
9)  Control of vectors and zoonosis  0  Malaria, dengue, rabies, toxoplasmosis
IO) Oral health  0  Buccodental hygiene
I)  Water quality  0  Testing and monitoring of wells and tap water
2)  Immunizations  0  Polio, DPT3, Measles, BCG,
3)  Family planning  0  Distribution of FP devices
4)  Prenatal, pregnancy and delivery care  0  Training and equipment for midwives
5)  Sexually transmitted diseases  0  Condom distribution in risk groups
6)  School health (5 - 15 years)  0  Ophthalmologic  tests, Buccodental health
7)  Well baby clinic (0 - 5 years)  0  Growth monitoring
8) Tuberculosis control  0  Supervised  treatment
9)  Strengthening of PHC infrastructure  0  Rehabilitation of PHC infrastructure
10) Training in PHC  0  Training of TAPS, Training of volunteer33
B.  Minimum Clinical Services
1)  Reproductive  health  0  Prenatal  care
0  Delivery  care
0  Treatment  of imminent  abortion
0  Family  planning
0  Sexually  transmitted  diseases
2) Child  health and school health  0  Acute  respiratory  diseases
0  Diarrhea
0  Rash and fever
O Meningitis
3) Infactious  diseases:  0  Tuberculosis
0  Intestinal  infections
0  Parasitic  diseases
0  Hepatitis
0  Geniot-urinary  infections
4)  Vector  borne diseases:  0  Malaria
0  Dengue
0  Onchocercosis
5)  Chronic  diseases:  0  Hypertension
0  Diabetes
0  Asthma
6)  Regular  diagnostic  consultation  0  Determination:  healthy-sick
7)  Limited  treatment  conditions:  0  AIDS
0  Pain management
0  Trauma
C. Discretionary  Clinical  Services  0  Acute  abdominal  condition
Treatment of
1) Cancer  0 Chemotheraphy,  Surgery
2)  Cardiovascular diseases  0  Surgery, CAT scanning
3)  Major Trauma  0  Grafting, surgery
4)  Neurological disorder  0  Scanning, surgery
5)  Psychiatric  0  Consultation, longer ib-patient stay34
TECHNICAL  ANNEX  B
Table 1: Regression Estimates of Infant Mortality Rate
Period  log  log  Safe  Sani  DPT3  Adj
Income  Health  water  tation  R2
Expenditure
OLS estimates
China  1982-93  -0.688  0.249  -0.234  -0.154  0.134  0.55
(-9.82)  (4.44)  (-4.17)  (-1.81)  (1.13)
Malaysia  1986-89  -0.34  -0.107  -0.133  0.65
(-0.27)  (-2.81)  (-5.54)
Philippines  1982-90  -0.42  0.981  -0.963  -0.846  -0.324  0.49
(-0.84)  (1.97)  (-4.39)  (-3.34)  (-2.17)
Viet Nam  1986-90  -0.241  0.099  -0.266  -0.081  -0.982  0.78
(-7.53)  (2.54)  (-4.09)  (-1.21)  (-3.18)
Fixed effects
China  1982-93  0.049  -0.114  0.052  -0.286  -0.259  0.96
(1.28)  (-2.20)  (1.31)  (-3.40)  (-2.19)
Malaysia  1986-89  -0.622  -0.102  -0.063  0.88
(-0.11)  (-1.41)  (-2.11)
Philippines  1982-90  -0.862  -0.233  -0.730  -0.748  -0.741  0.98
(-6.96)  (-2.35)  (-1.72)  (-1.27)  (-2.81)
VietNam  1986-90  -0.448  0.008  -0.082  -0.023  -0.415  0.97
-4.48)  (0.42)  (-0.85)  (-0.56)  (-2.39)
Random effects
China  1982-93  -0.509  -0.531  -0.200  -0.242  0.21
-6.97)  (-8.16)  (-0.83)  (-3.15)
Malaysia  1986-89  0.45  -0.116  0.075  0.62
(0.21)  (-2.32)  (3.75)
Philippines  1982-90  -0.866  -0.205  -0.815  -0.89  -0.749  0.20
(-7.03)  (-2.17)  (-1.93)  (-1.52)  (-2.84)
Viet Nam  1986-90  -0.242  0.082  -0.214  -0.092  -0.687  0.81
(-8.66)  (5.86)  (-8.56)  (-4.01)  (-6.19)
Note: T-statistics are in the parentheses35
(a) Although  Hausman-Wu  test shows  fixed  effect estimates  better,  estimated  coefficients  for Viet  Nam are superior
in random  effects  model  than in any other  models.(b)  see Hammer  (1992):  "Malaysia:  Fiscal Reform  for Stable
Growth"  (10120-MA)  for Malaysian  data (c) Similar  regressions  on life  expectancy  at birth are not presented  as the
central  message  remains  the same
Table  2: Regression  Estimates  of the Determinants  of Infant  Mortality  (29 provinces  1982-92)
Right  hand side variables  Fixed-effect  Model  T-statistics
Per capita  provincial  Income  -0.448  -6.05
Sanitation  -0.270  -3.64
DPT3  -0.165  -1.91
Per capita  provincial  health  -0.564  -7.94
expenditure
Interaction  income  x health  -0.190  -7.94
expenditure
Adjusted  R2  0.970
Source:  Staff calculations  with data from MOHPolicy  Research  Working  Paper Series
Contact
Title  Author  Date  for paper
WPS1787  Trading Arrangements and  Diego Puga  June 1997  J. Ngaine
Industrial Development  Anthony J. Venables  37947
WPS1788  An Economic Analysis of Woodfuel  Kenneth M. Chomitz  June 1997  A. Maranon
Management in the Sahel: The Case  Charles Griffiths  39074
of Chad
WPS1789  Competition Law in Bulgaria After  Bernard Hoekman  June 1997  J. Ngaine
Central Planning  Simeon Djankov  37947
WPS1790  Interpreting the Coefficient of  Barry R. Chiswick  June 1997  P. Singh
Schooling  in the Human Capital  85631
Earnings Function
WPS1791  Toward Better Regulation of Private  Hemant Shah  June 1997  N. Johl
Pension Funds  38613
WPS1792  Tradeoffs from Hedging: Oil Price  Sudhakar Satyanarayan  June 1997  E. Somensatto
Risk in Ecuador  30128
WPS1793  Wage and Pension Pressure on the  Alain de Crombrugghe  June 1997  M. Jandu
Polish Budget  33103
WPS1794  Ownership Structure, Corporate  Xiaonian Xu  June 1997  J. Chinsen
Governance, and Corporate  Yan Wang  34022
Performance: The Case of Chinese
Stock Companies
WPS1795  What  Educational Production  Lant Pritchett  July 1997  S. Fallon
Functions Really Show: A Positive  Deon Filmer  38009
Theory of Education Spending
WPS1796  Cents and Sociability: Household  Deepa Narayan  July 1997  S. Fallon
Income and Social Capital in Rural  Lant Pritchett  38009
Tanzania
WPS1797  Formal and Informal  Regulation  Sheoli Pargal  July 1997  E. de Castro
of Industrial Pollution:  Hemamala Hettige  89121
Comparative  Evidence from  Manjula Singh
Indonesia and the United States  David Wheeler
WPS1798  Poor Areas, Or Only Poor People?  Martin Ravallion  July 1997  P. Sader
Quentin Wodon  33902
WPS1799  More for the Poor Is Less for the  Jonath B. Gelbach  July 1997  S. Fallon
Poor: The Politics of Targeting  Lant H. Pritchett  38009
WPS1 800 Single-Equation  Estimation of the  John Baffes  August 1997  P. Kokila
Equilibrium  Real Exchange Rate  Ibrahim A. Elbadawi  33716
Stephen A. O'ConnellPolicy Research  Working Paper Series
Contact
Title  Author  Date  for paper
WPS1801  Regional Integration as Diplomacy  Maurice Schiff  August 1997  J. Ngaine
L. Alan Winters  37947
WPS1 802 Are There Synergies Between  Harry Huizinga  August 1997  P. Sintim-Aboagye
World  Bank Partial Credit  38526
Guarantees and Private Lending?
WPS1803  Fiscal Adjustments  in Transition  Barbara Fakin  August  1997  M. Jandu
Economies: Social Transfers and the  Alain de Crombrugghe  33103
Efficiency of Public Spending: A
Comparison  with OECD Countries
WPS1 804 Financial Sector Adjustment Lending:  Robert J. Cull  August 1997  P. Sintim-Aboagye
A Mid-Course Analysis  37644
WPS1805  Regional Economic Integration and  Junichi Goto  August 1997  G.  llogon
Agricultural Trade  33732
WPS1806  An International Statistical Survey  Salvatore Schiavo-Campo  August 1997  M. Gueverra
of Government Employment and  Giulio de Tommaso  32959
Wages  Amitabah Mukherjee
WPS1807  The Ghosts of Financing Gap:  William  Easterly  August 1997  K. Labrie
How the Harrod-Domar Growth  31001
Model Still Haunts Development
Economics
WPS1808  Economic Transition  and the  Francisco H. G. Ferreira  August 1997  M. Geller
Distributions  of Income and Wealth  31393
WPS1809  Institutions in Transition: Reliability  Aymo Brunetti  August 1997  M. Geller
of Rules and Economic Performance  Gregory Kisunko  31393
in Former Socialist Countries  Beatrice Weder
WPS1810  Inspections and Emissions in India:  Sheoli Pargal  August 1997  E. Krapf
Puzzling Survey Evidence about  Muthukumara Mani  80513
Mainul Huq
WPS1811  Agricultural  Development: Issues,  Yair Mundiak  August 1997  P. Kokila
Evidence, and Consequences  Donald F. Larson  33716
Al Crego
WPS1 812 Managing Guarantee programs in  Michael Klein  August 1997  S. Vivas
Support of Infrastructure Investment  82809